Free Trial

Nano-X Imaging (NNOX) Competitors

Nano-X Imaging logo
$5.32 +0.22 (+4.31%)
Closing price 04/24/2025 04:00 PM Eastern
Extended Trading
$5.26 -0.06 (-1.03%)
As of 09:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NNOX vs. FNA, TNDM, INMD, BLFS, MDXG, AORT, EYE, ESTA, AXGN, and IRMD

Should you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Paragon 28 (FNA), Tandem Diabetes Care (TNDM), InMode (INMD), BioLife Solutions (BLFS), MiMedx Group (MDXG), Artivion (AORT), National Vision (EYE), Establishment Labs (ESTA), AxoGen (AXGN), and Iradimed (IRMD). These companies are all part of the "medical equipment" industry.

Nano-X Imaging vs.

Nano-X Imaging (NASDAQ:NNOX) and Paragon 28 (NYSE:FNA) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment, community ranking and earnings.

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 63.6% of Paragon 28 shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by company insiders. Comparatively, 15.3% of Paragon 28 shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Nano-X Imaging has a beta of 2.03, meaning that its stock price is 103% more volatile than the S&P 500. Comparatively, Paragon 28 has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500.

Nano-X Imaging currently has a consensus target price of $12.00, indicating a potential upside of 125.56%. Paragon 28 has a consensus target price of $14.20, indicating a potential upside of 8.36%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, equities analysts clearly believe Nano-X Imaging is more favorable than Paragon 28.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Paragon 28
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Paragon 28 has a net margin of -25.31% compared to Nano-X Imaging's net margin of -465.38%. Nano-X Imaging's return on equity of -27.63% beat Paragon 28's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-465.38% -27.63% -24.72%
Paragon 28 -25.31%-37.90%-18.22%

Paragon 28 received 1 more outperform votes than Nano-X Imaging when rated by MarketBeat users. Likewise, 74.47% of users gave Paragon 28 an outperform vote while only 73.91% of users gave Nano-X Imaging an outperform vote.

CompanyUnderperformOutperform
Nano-X ImagingOutperform Votes
34
73.91%
Underperform Votes
12
26.09%
Paragon 28Outperform Votes
35
74.47%
Underperform Votes
12
25.53%

Paragon 28 has higher revenue and earnings than Nano-X Imaging. Paragon 28 is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$11.28M27.24-$60.78M-$0.90-5.91
Paragon 28$256.18M4.29-$57.53M-$0.63-20.80

In the previous week, Paragon 28 had 6 more articles in the media than Nano-X Imaging. MarketBeat recorded 9 mentions for Paragon 28 and 3 mentions for Nano-X Imaging. Paragon 28's average media sentiment score of 0.72 beat Nano-X Imaging's score of 0.45 indicating that Paragon 28 is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nano-X Imaging
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Paragon 28
3 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Paragon 28 beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NNOX vs. The Competition

MetricNano-X ImagingX IndustryBusiness SectorNASDAQ Exchange
Market Cap$307.38M$11.32B$7.14B$7.70B
Dividend YieldN/A2.05%2.65%4.32%
P/E Ratio-6.2616.9430.5918.33
Price / Sales27.248.13160.57107.05
Price / CashN/A11.9031.6134.62
Price / Book1.502.034.814.25
Net Income-$60.78M$344.53M$195.43M$247.51M
7 Day Performance2.31%3.73%18.08%6.33%
1 Month Performance-9.83%-11.60%-0.83%-3.33%
1 Year Performance-40.36%19.07%9.30%5.15%

Nano-X Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NNOX
Nano-X Imaging
1.7473 of 5 stars
$5.32
+4.3%
$12.00
+125.6%
-41.5%$307.38M$11.28M-6.26190
FNA
Paragon 28
1.5971 of 5 stars
$13.11
+0.1%
$14.20
+8.4%
+35.8%$1.10B$256.18M-17.71343,000High Trading Volume
TNDM
Tandem Diabetes Care
4.2766 of 5 stars
$16.32
-3.2%
$43.88
+168.9%
-49.7%$1.09B$940.20M-8.462,600Upcoming Earnings
News Coverage
Positive News
INMD
InMode
2.0199 of 5 stars
$14.83
-0.6%
$21.25
+43.3%
-7.1%$1.03B$394.82M6.31480Upcoming Earnings
BLFS
BioLife Solutions
2.3716 of 5 stars
$20.99
-4.2%
$31.17
+48.5%
+44.3%$997.03M$82.25M-19.80440Analyst Downgrade
Positive News
MDXG
MiMedx Group
3.1427 of 5 stars
$6.55
-1.9%
$12.00
+83.2%
+5.8%$965.25M$348.88M11.91870Upcoming Earnings
AORT
Artivion
2.9695 of 5 stars
$22.47
-2.0%
$31.40
+39.7%
+14.0%$959.22M$388.54M-1,123.501,300News Coverage
Positive News
EYE
National Vision
1.8859 of 5 stars
$10.98
-5.9%
$14.00
+27.5%
-31.4%$865.04M$1.82B-54.9014,000Positive News
ESTA
Establishment Labs
2.1468 of 5 stars
$29.12
-7.4%
$57.40
+97.1%
-39.1%$840.00M$166.03M-11.29960Gap Up
AXGN
AxoGen
2.9362 of 5 stars
$14.95
-4.0%
$22.60
+51.2%
+135.2%$662.94M$187.34M-46.72450Upcoming Earnings
News Coverage
IRMD
Iradimed
4.8979 of 5 stars
$50.35
-2.7%
$72.00
+43.0%
+25.2%$640.20M$73.24M33.57110Upcoming Earnings
News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:NNOX) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners